NFL Biosciences Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Dec '21 Dec 31, 2021	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.04	3.04	0.31
Short-Term Investments	0.17	0.17	-
Cash & Short-Term Investments	3.2	3.2	0.31
Cash Growth	-	933.15%	-
Other Receivables	0.22	0.22	0.16
Receivables	0.22	0.22	0.16
Prepaid Expenses	0.13	0.13	-
Total Current Assets	3.56	3.56	0.47
Property, Plant & Equipment	0	0	-
Long-Term Investments	0	0	-
Other Intangible Assets	0.12	0.12	0.11
Total Assets	3.69	3.69	0.58
Accounts Payable	0.12	0.12	0.05
Accrued Expenses	0.07	0.07	-
Short-Term Debt	0	0	-
Current Income Taxes Payable	-	-	0.04
Other Current Liabilities	-	-	0
Total Current Liabilities	0.19	0.19	0.09
Long-Term Debt	0.09	0.09	0.09
Other Long-Term Liabilities	0.13	0.13	0.25
Total Liabilities	0.4	0.4	0.43
Common Stock	0.16	0.16	0.39
Additional Paid-In Capital	4.11	4.11	1.85
Retained Earnings	-0.98	-0.98	-2.09
Shareholders' Equity	3.29	3.29	0.15
Total Liabilities & Equity	3.69	3.69	0.58
Total Debt	0.09	0.09	0.09
Net Cash (Debt)	3.12	3.12	0.23
Net Cash Growth	-	1285.36%	-
Net Cash Per Share	0.60	0.60	-
Filing Date Shares Outstanding	5.23	5.23	-
Total Common Shares Outstanding	5.23	5.23	-
Working Capital	3.37	3.37	0.38
Book Value Per Share	0.63	0.63	-
Tangible Book Value	3.16	3.16	0.04
Tangible Book Value Per Share	0.60	0.60	-
Machinery	0.04	0.04	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.